An uncommon association of dry eye syndrome with relapsing polychondritis and necrotizing scleritis

被引:1
|
作者
Nicula, Cristina Ariadna [1 ]
Suciu, Corina [2 ]
Bojan, Anca [3 ]
Damian, Laura [2 ]
Bulboaca, Adriana Elena [4 ]
机构
[1] Med & Pharm Univ Iuliu Hatieganu, Dept Ophthalmol, Cluj Napoca, Romania
[2] Emergency Cty Hosp, Cluj Napoca, Romania
[3] Med & Pharm Univ Iuliu Hatieganu, Dept Hematol, Cluj Napoca, Romania
[4] Med & Pharm Univ Iuliu Hatieganu, Dept Physiopathol, Cluj Napoca, Romania
关键词
relapsing polychondritis; dry eye; necrotizing scleritis; MYELODYSPLASTIC SYNDROMES; AUTOIMMUNITY; DEFICIENCY; DISORDERS;
D O I
10.12680/balneo.2020.341
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Introduction Relapsing polychondritis (RP) is a rare disease evolving with recurrent cartilage inflammation, but also with ocular, respiratory, cardiac and vascular involvement. Associations with various autoimmune disorders and with hematological diseases, mainly leukemia, lymphoma and myelodysplastic syndrome and rarely with hemolytic anemia, have been described. We report a 63-year patient with thyroiditis and pernicious anemia in whom a left eye necrotizing scleritis led to the diagnosis of RP and common variable immune deficiency (CVID). The necrotizing scleritis was successfully operated with scleral graft. However, the disease control was difficult to be achieved with glucocorticoids and various immune suppression regimens tried (including cyclophosphamide, cyclosporine, azathioprine, leflunomide and infliximab) along with immunoglobulin substitution. The association of RP and CVID or CVID-like diseases is rare, another 4 cases having been reported. We review the literature and discuss the diagnostic and management difficulties. A multidisciplinary team approach is necessary in this setting.
引用
收藏
页码:204 / 209
页数:6
相关论文
共 50 条
  • [21] The successful use of infliximab in resistant relapsing polychondritis and associated scleritis
    S Cazabon
    K Over
    J Butcher
    Eye, 2005, 19 : 222 - 224
  • [22] Successful treatment with tocilizumab for refractory scleritis associated with relapsing polychondritis
    Shimizu, H.
    Nishioka, H.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 418 - 419
  • [23] Hypopyron uveitis (without scleritis) a manifestation symptom of relapsing polychondritis
    Genevois, Olivier
    Calenda, E.
    Nasser, Z.
    Benzerroug, M.
    Gardea, E.
    Muraine, M.
    ANNALS OF OPHTHALMOLOGY, 2009, 41 (3-4) : 208 - 211
  • [24] The successful use of infliximab in resistant relapsing polychondritis and associated scleritis
    Cazabon, S
    Over, K
    Butcher, J
    EYE, 2005, 19 (02) : 222 - 224
  • [25] EFFICACY OF ORAL TACROLIMUS IN TWO PATIENTS WITH SCLERITIS AND RELAPSING POLYCHONDRITIS
    Cavalli, G.
    Campochiaro, C.
    Berti, A.
    Guglielmi, B.
    Sabbadini, M. G.
    Dagna, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1004 - 1004
  • [26] The association of relapsing polychondritis and myelodysplastic syndrome - Report of three cases
    Salahuddin, N
    Libman, BS
    Lunde, JH
    Kay, J
    Cooper, SM
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2000, 6 (03) : 146 - 149
  • [27] Antiphospholipid syndrome and relapsing polychondritis
    Piette, JC
    Papo, T
    Amoura, Z
    Bletry, O
    Marie, L
    Saada, V
    Frances, C
    Godeau, P
    REVUE DE MEDECINE INTERNE, 1997, 18 (02): : 172 - 173
  • [28] RELAPSING POLYCHONDRITIS AND MYELODYSPLASTIC SYNDROME
    LAVABREBERTRAND, T
    NAVARRO, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1993, 43 (03) : 243 - 243
  • [29] Recognizing The Pattern: Relapsing Polychondritis Presenting With Recurrent Otitis Externa And Scleritis
    Abu Homoud, A.
    Alpert, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [30] Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis
    Damian, L.
    Pamfil, C.
    Bucsa, C.
    Nicula, C.
    Mouthon, L.
    Amoura, Z.
    Cutolo, M.
    Burmester, G. R.
    Fonseca, J. E.
    Grapini, L.
    Arnaud, L.
    Rednic, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (05) : S86 - S92